Second, the Panc 02 subcutaneously transplanted tumor model does not fully mimic changes in tumor progression in human pancreatic cancer, and we plan to further validate the therapeutic value of targeting ZDHHC3 as well as 2-BP treatment in a spontaneous pancreatic cancer tumor model in the future study. The gene discussed is ZDHHC3; the disease is familial pancreatic carcinoma.